drugset / Trial / NCT04335617

Micronized Purified Flavonoid- Fraction (MPFF) in the Management of Radiation Proctitis

NCT04335617 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

national and multi-center trial for medical therapy of chronic radiation proctitis inducing anorectal bleedings

Timeline

Start
2020-02-26
Primary completion
2023-02-26
Completion
2023-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Micronized purified Flavonoid-Fraction Unknown 500 mg Oral

Indications